Screening for blunt cerebrovascular injuries in pediatric trauma patients

Michael U Mallicote1, Mubina A Isani1, Jamie Golden1

  • 1Children's Hospital Los Angeles, Los Angeles, CA.

Insights

Current adult screening criteria for blunt cerebrovascular injuries (BCVI) lead to many unnecessary CT angiograms (CTA) in pediatric trauma patients. New, more accurate criteria are needed for this population.

Area of Science:

  • Pediatric Traumatology
  • Vascular Imaging
  • Emergency Medicine

Background:

  • Adult screening criteria for blunt cerebrovascular injuries (BCVI), the Denver and Memphis criteria, are routinely applied to pediatric trauma patients.
  • These guidelines recommend CT angiogram (CTA) for patients meeting any positive screening criterion.
  • The extrapolation of adult criteria to children may result in unnecessary imaging and associated risks.

Purpose of the Study:

  • To evaluate the effectiveness of the Denver and Memphis criteria for screening pediatric blunt trauma patients for BCVI.
  • To determine the rate of unnecessary CTAs performed in pediatric trauma patients based on current screening guidelines.
  • To identify potential new criteria for BCVI screening in children.

Main Methods:

  • A retrospective study at a single center analyzed 2795 trauma patients over 9 years.
  • A large-scale retrospective chart review of 776,355 pediatric trauma patients from the National Trauma Data Bank (NTDB) (2007-2014) was conducted.
  • Data included patients aged 0-18, utilizing ICD-9 codes for BCVI and screening criteria.

Main Results:

  • In the NTDB cohort, 81,294 pediatric patients met Denver/Memphis criteria, but only 2136 had BCVI.
  • Strict adherence to these criteria would have resulted in 79,158 (97.4%) negative CTAs.
  • Multivariate analysis identified skull base fracture, cervical spine fractures (with or without cord injury), traumatic jugular venous injury, and cranial nerve injury as significant indicators for BCVI screening.

Conclusions:

  • The Denver and Memphis criteria are inadequate for screening pediatric blunt trauma patients for BCVI.
  • A significant number of pediatric patients undergo unnecessary CTAs when these adult-derived criteria are strictly applied.
  • Revised screening criteria, incorporating specific injury patterns, are necessary to improve the diagnostic yield of CTA in pediatric BCVI evaluation.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
276
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
200
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
261
Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.6K
Burn Injuries01:22

Burn Injuries

Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
4.3K